Home > Healthcare > Pharmaceuticals > Drug Delivery > Softgel Capsules Market

Softgel Capsules Market Trends

Report ID: GMI5272
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Softgel Capsules Market Trends

Rising demand for plant-based capsules attributed to the surging awareness of sustainability, eco-friendliness, and preference for natural, vegetarian/vegan-friendly products will generate lucrative opportunities for market growth. Plant-based capsules are free from common allergens like dairy, gluten, and soy, making them a safer option for a broader range of people. Manufacturers are developing new plant-based materials that offer enhanced functionality and performance as capsule shells. Such innovations will further help strengthen the market outlook.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of softgel capsules was worth more than USD 8.9 billion in 2022and will grow at 5.5% CAGR from 2023 to 2032, attributed to the growing occurrence of chronic disorders globally.

Gelatin-based softgel capsules market was valued at over USD 8 billion in 2022, owing to their superior pH-dependent gelling and thermo-reversibility properties.

North America market size for softgel capsules will reach more than USD 3.9 billion by 2032, attributed to the surging healthcare spending in the region.

Major softgel capsules industry players include Procaps Group, Fuji Capsules Co. Ltd., Estrellus, Delpharm Evreux, Captek Softgel International Inc., Patheon, and Guangdong Yichao Biological Co. Ltd., among others.